BR1010
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BR1010, covering 2021-07-30 to 2021-07-30. Get the full timeline:
Most recent: Clinical Trial Update: BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination [Phase 3]